NCT04924777

Brief Summary

The study design is to determine the effectiveness of moderate physical activity on g;lycemic control in type 2 diabetes mellitus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable type-2-diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 11, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 14, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
Last Updated

November 26, 2021

Status Verified

November 1, 2021

Enrollment Period

4 months

First QC Date

June 11, 2021

Last Update Submit

November 24, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • HbA1c Levels

    Reduction in HbA1c levels

    3 months

Study Arms (3)

Brisk walk

EXPERIMENTAL
Other: Brisk WalkOther: Strength trainingOther: Aerobic Exercises

Aerobic Training

EXPERIMENTAL
Other: Brisk WalkOther: Strength trainingOther: Aerobic Exercises

Strength Training

EXPERIMENTAL
Other: Brisk WalkOther: Strength trainingOther: Aerobic Exercises

Interventions

1-Brisk walk for 30 minutes 2-5 days a week 3-3months

Aerobic TrainingBrisk walkStrength Training

1-Strength Training Exercises for 30 minutes. 2-5 days a week 3-3 months

Aerobic TrainingBrisk walkStrength Training

1-Aerobic exercises for 30 minutes 2-5 Days a week 3-3months

Aerobic TrainingBrisk walkStrength Training

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants falling in this category would be recruited into the study.
  • Male/female
  • Diabetic type 2 patients
  • Age: 30-70 years
  • BMI \>25
  • Overweight
  • Fat % in male\> 25
  • Fat % in female \>35
  • HbA1c level more than 48mmol/mol or \>6.5%
  • Fasting Plasma Glucose level \>126 mg/dl (7.0 mmol/l)
  • Random Plasma glucose level \>200 mg/dl (11.1 mmol/l)
  • Physically active ( have no mobility problems)

You may not qualify if:

  • Participant failing to fall in this category would be excluded of the study.
  • Type 1 diabetes
  • Insulin dependant type 2 diabetes
  • Gestational Diabetes
  • Hypertension
  • Cigarette smoking
  • Cardiovascular Disease
  • Cerebrovascular disease
  • Cardiopulmonary Disorders
  • Cognition Problems
  • Peripheral Artery Disease
  • Dyslipidemia
  • Proliferative or preproliferative retinopathy
  • Nephropathy
  • Neuropathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riphah Rehabilitation Center

Islamabad, 44000, Pakistan

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Resistance TrainingExercise

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Waqar Ahmad Awan

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2021

First Posted

June 14, 2021

Study Start

April 1, 2021

Primary Completion

July 31, 2021

Study Completion

July 31, 2021

Last Updated

November 26, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations